CheekAge test, developed by Tally Health, estimates mortality risk through DNA methylation, outperforming blood-based tests.

A new test called CheekAge, developed by Tally Health, estimates mortality risk through a non-invasive cheek swab that analyzes DNA methylation. This method significantly outperforms earlier blood-based tests. A study involving 1,513 older adults found that higher CheekAge correlates with increased mortality risk. Researchers aim to explore links between specific genes and aging, potentially aiding in lifestyle changes and medical prescriptions to improve health outcomes.

September 30, 2024
26 Articles